14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.630 2 days ( -5.30 % )
Last Price $31.81 5.30 %
High/ Low $30.40 - $33.02 14.08%
Chg 7 Days 10.45 % $28.80 $31.81
Chg 30 Days 6.46 % $29.88 $31.81
Chg 12 mos 41.31 % $22.51 $31.81
Trend - 3 mos 19.42 % Width: 39.41 %
Trend - 12 mos 5.97 % Width: 67.84 %
Pred. range - 3 mos $33.22 - $46.31 4.42 % - 45.57 %
Pred. range - 12 mos $22.17 - $37.21 -30.30 % - 16.99 %
Short MA avg 3 mos Buy Apr 18, 2024 - 4 days
Long MA avg 3 mos Buy Apr 19, 2024 - 3 days
Short/Long MA avg 3 mos Buy Apr 22, 2024 - 2 days
Short MA avg 12 mos Buy Apr 17, 2024 - 5 days
Long MA avg 12 mos Buy Jan 31, 2024 - 58 days
Short/Long MA avg 12 mos Buy Feb 08, 2024 - 52 days
Pivot Short Sell Feb 27, 2024 - 40 days
Bollinger Buy Apr 23, 2024 - 1 day
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT